Cinctive Capital Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-25,000
Closed -$8.11M 550
2022
Q2
$8.11M Buy
25,000
+15,000
+150% +$4.5M 0.34% 91
2022
Q1
$2.86M Buy
+10,000
New +$2.57M 0.11% 276

Other funds holding LLY

Cinctive Capital Management's LLY Position: Q2 2026 in Review

Cinctive Capital Management increased its Eli Lilly (LLY) stake by 19% in Q2 2026, buying an estimated $1.94M and bringing the position to 11,910 shares worth $14.3M. The position accounts for 0.53% of the portfolio, ranked #49.

Cinctive Capital Management first reported a position in LLY in Q3 2020 and has held it in 12 quarters since. 4,624 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Cinctive Capital Management held 11,910 shares of Eli Lilly worth $14.3M as of Q2 2026.
  • Cinctive Capital Management bought 1,902 Eli Lilly shares in Q2 2026, an estimated $1.94M.
  • Eli Lilly made up 0.53% of Cinctive Capital Management's portfolio in Q2 2026, its #49 holding.
  • Cinctive Capital Management first reported a position in Eli Lilly in Q3 2020 and has held it in 12 quarters since.
  • 4,624 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Cinctive Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.